Skuldtech
About:
Skuldtech innovates diagnostics associated with new treatments for cancer and neurodegenerative and infectious diseases.
Website: http://skuldtech.com
Top Investors: Bpifrance
Description:
Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications. This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics associated with new treatments, especially in cancer, neurodegenerative and infectious diseases.
Total Funding Amount:
1M EUR
Headquarters Location:
New York, New York, United States
Founded Date:
1999-01-01
Contact Email:
info(AT)skuldtech.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2013-09-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai